Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1981 3
1983 2
1984 1
1985 6
1986 1
1987 5
1988 2
1989 6
1990 6
1991 4
1992 3
1993 7
1994 3
1995 4
1996 6
1997 6
1998 7
1999 6
2000 5
2001 5
2002 5
2003 7
2004 3
2005 9
2006 8
2007 6
2008 10
2009 5
2010 8
2011 3
2012 3
2013 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
Culprit and victim -- DNA topoisomerase II.
Kellner U, Sehested M, Jensen PB, Gieseler F, Rudolph P. Kellner U, et al. Among authors: sehested m. Lancet Oncol. 2002 Apr;3(4):235-43. doi: 10.1016/s1470-2045(02)00715-5. Lancet Oncol. 2002. PMID: 12067686 Review.
Dexrazoxane in anthracycline extravasation.
Langer SW, Sehested M, Jensen PB, Buter J, Giaccone G. Langer SW, et al. Among authors: sehested m. J Clin Oncol. 2000 Aug;18(16):3064. J Clin Oncol. 2000. PMID: 10944144 No abstract available.
Anticancer agent CHS-828 inhibits cellular synthesis of NAD.
Olesen UH, Christensen MK, Björkling F, Jäättelä M, Jensen PB, Sehested M, Nielsen SJ. Olesen UH, et al. Among authors: sehested m. Biochem Biophys Res Commun. 2008 Mar 21;367(4):799-804. doi: 10.1016/j.bbrc.2008.01.019. Epub 2008 Jan 15. Biochem Biophys Res Commun. 2008. PMID: 18201551
152 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page